Inflammatory Bowel Disease (IBD) patients frequently report adverse drug reactions during biologic therapy: A multicentre, prospective, patient-reported pharmacovigilance monitoring system

被引：0
|
作者：
Thomas, P. [1 ]
West, R. [2 ]
Russel, M. [3 ]
Jansen, J. [4 ]
Van Lint, J. [5 ]
Jessurun, N. [5 ]
Romkens, T. [6 ]
Hoentjen, F. [1 ]
机构：
[1] Radboud Univ Nijmegen, Gastroenterol, Med Ctr, Nijmegen, Netherlands
[2] Franciscus Gasthuis & Vlietland, Gastroenterol, Rotterdam, Netherlands
[3] Med Spectrum Twente, Gastroenterol, Enschede, Netherlands
[4] Onze Lieve Vrouw Gasthuis, Gastroenterol, Amsterdam, Netherlands
[5] Pharmacovigilance Ctr LAREB, Pharmacovigilancy, Shertogenbosch, Netherlands
[6] Jeroen Bosch Ziekenhuis, Gastroenterol, Shertogenbosch, Netherlands
来源：
JOURNAL OF CROHNS & COLITIS | 2020年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P330
引用
收藏
页码：S319 / S319
页数：1
相关论文
共 47 条
  • [1] Inflammatory bowel disease patients provide reliable self-reported medical information: A multicentre prospective pharmacovigilance monitoring system
    Thomas, Pepijn W. A.
    West, Rachel L.
    Russel, Maurice G. V. M.
    Jansen, Jeroen M.
    Kosse, Leanne J.
    Jessurun, Naomi T.
    Romkens, Tessa E. H.
    Hoentjen, Frank
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 (04) : 520 - 524
  • [2] COMPARISONS OF HOLISTIC PATIENT-REPORTED OUTCOMES BY BIOLOGIC DRUG CLASS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A REAL-WORLD STUDY IN IBD PARTNERS
    Long, Millie
    Zhang, Xian
    Chen, Wenli
    Lissoos, Trevor
    [J]. INFLAMMATORY BOWEL DISEASES, 2020, 26 : S23 - S24
  • [3] COMPARISONS OF HOLISTIC PATIENT-REPORTED OUTCOMES BY BIOLOGIC DRUG CLASS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A REAL-WORLD STUDY IN IBD PARTNERS
    Long, Millie
    Zhang, Xian
    Chen, Wenli
    Lissoos, Trevor
    [J]. GASTROENTEROLOGY, 2020, 158 (03) : S38 - S38
  • [4] POTENTIAL PATIENT-REPORTED PREDICTORS OF OPENNESS TO AND PREFERENCE FOR BIOLOGIC THERAPY AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Goren, A.
    Teeple, A.
    Ingham, M.
    [J]. VALUE IN HEALTH, 2015, 18 (03) : A300 - A300
  • [5] Changes in Patient-Reported Outcomes With Vedolizumab Therapy in Patients With Inflammatory Bowel Diseases (IBD)
    Long, Millie D.
    Martin, Christopher
    Chen, Wenli
    Jaeger, Elizabeth
    Barocas, Morris
    Luo, Michelle
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S342 - S342
  • [6] ADVERSE DRUG REACTIONS DURING BIOLOGIC THERAPY IN INFLAMMATORY DISEASE: REAL LIFE DATA FROM THE PHARMACOVIGILANCE PROJECT IN THE CALABRIA REGION
    Larussa, T.
    Palleria, C.
    Naturale, M. D.
    Vero, A.
    Manti, A.
    Iannone, L.
    Spagnuolo, R.
    Doldo, P.
    Citraro, R.
    Russo, E.
    Abenavoli, L.
    De Sarro, G.
    Luzza, F.
    [J]. DIGESTIVE AND LIVER DISEASE, 2019, 51 : E235 - E235
  • [7] Prospective Therapeutic Drug Monitoring to Optimizing Infliximab (IFX) Maintenance Therapy in Patients With Inflammatory Bowel Disease (IBD)
    Vaughn, Byron P.
    Martinez-Vazquez, Manuel
    Patwardhan, Vilas
    Moss, Alan C.
    Sandborn, William J.
    Cheifetz, Adam S.
    [J]. GASTROENTEROLOGY, 2014, 146 (05) : S54 - S54
  • [8] Discrepancy between patient- and healthcare provider-reported adverse drug reactions in inflammatory bowel disease patients on biological therapy
    Thomas, Pepijn W. A.
    Romkens, Tessa E. H.
    West, Rachel L.
    Russel, Maurice G. V. M.
    Jansen, Jeroen M.
    van Lint, Jette A.
    Jessurun, Naomi T.
    Hoentjen, Frank
    [J]. UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2021, 9 (08) : 919 - 928
  • [9] Biologic Therapy and Therapeutic Drug Monitoring in Patients With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis
    Varun, Jain
    Brian, Behm
    Esteban, Figueroa
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S5 - S5
  • [10] Changes in Patient-Reported Outcomes With Vedolizumab Therapy in Patients With Inflammatory Bowel Diseases (IBD): Results From the IBD Partners Patient Powered Research Network
    Long, Millie D.
    Martin, Christopher F.
    Chen, Wenli
    Luo, Michelle
    [J]. CROHNS & COLITIS 360, 2019, 1 (02)
12345